Spyre Therapeutics

Spyre Therapeutics (operating at spyre.com) is a clinical-stage biotechnology company engineered for developing next-generation therapies that elevate the standard in immunology. Founded in 2023 and headquartered in Waltham, MA, Spyre Therapeutics aims to create next-generation inflammatory bowel disease (IBD) and other immune-mediated therapies. Under the hood, the company focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD). This allows patients to receive effective treatments for their conditions. Backed by its first funding round within a year of its incorporation.